
ROS1-Positive Cancer Targeted Therapy
ROS1-positive cancer targeted therapy in India for selected advanced NSCLC after molecular confirmation, using ROS1 inhibitors with oncology monitoring and imaging follow-up.
Related Conditions
Our services are FREE and by using our services your hospital bill does not increase!
About ROS1-Positive Cancer Targeted Therapy
ROS1-positive cancer targeted therapy in India is used mainly for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that carries a ROS1 gene fusion or rearrangement. Treatment uses a ROS1-targeted tyrosine kinase inhibitor rather than standard chemotherapy alone when the molecular alteration is confirmed and the patient is clinically suitable.
Before treatment, patients usually need pathology confirmation and molecular testing using an appropriate method such as next-generation sequencing, FISH, PCR or another validated assay. Staging imaging, including brain imaging when indicated, helps define disease extent. The oncology team also reviews previous systemic therapy, performance status, other medicines and any known resistance mutation.
ROS1-targeted medicines used internationally include crizotinib, entrectinib and repotrectinib, with treatment choice influenced by previous ROS1 therapy, central-nervous-system disease, drug availability and the patient’s overall clinical situation. Treatment requires monitoring for drug-specific side effects and periodic imaging to assess response.
The cost of ROS1-targeted therapy in India depends mainly on the medicine selected, dose, treatment duration, molecular testing, imaging and oncology follow-up. Drug availability and pricing can vary between hospitals and pharmacies.
India offers access to thoracic oncologists, molecular pathology laboratories and multidisciplinary lung-cancer teams at tertiary cancer hospitals. Compare ROS1 testing, oncology expertise, available targeted medicines and estimated costs. Medical Help India can connect you with a suitable healthcare partner whose team can review pathology, molecular results, scans and previous treatment and advise on appropriate next steps.
What's Included
Why consider treatment in India?
Access to experienced specialists
Advanced treatment and diagnostic options
More affordable hospital care
Shorter waiting times for treatment
Help comparing hospitals, plans and costs
Support with appointments, travel and follow-up
Cost in India
USDFinal costs depend on the medical assessment, hospital, room category and clinical needs.
How it works
Share your details
Tell us about your health concerns, age and current location.
Receive a call
We call you to discuss your situation, needs and questions.
Receive a treatment plan
Get information about the most suitable treatment plan, hospital and estimated cost.
Choose your plan
Review the options and agree on your care and travel plan.
Get full support
Receive full support throughout every stage of your care journey.
Receive care in India
Receive your planned care with support throughout your stay.
Top Hospitals for ROS1-Positive Cancer Targeted Therapy
View All Hospitals →Top Doctors for ROS1-Positive Cancer Targeted Therapy
View All Doctors →Frequently Asked Questions
How much does ROS1-Positive Cancer Targeted Therapy cost in India?
Cost depends mainly on the selected ROS1 inhibitor, dose, treatment duration, molecular testing, imaging and oncology follow-up. Prices and availability of crizotinib, entrectinib or repotrectinib can vary by provider and treatment line.
Which medical reports are useful to have ready for ROS1-Positive Cancer Targeted Therapy?
Have ready: pathology confirming the cancer type, the ROS1 molecular report, staging scans including brain imaging when performed, previous systemic-treatment history and current medicines. Include any resistance-testing results after prior ROS1-targeted therapy.
How is ROS1-positive cancer confirmed?
A tumour sample is tested for a ROS1 fusion or rearrangement using a validated molecular method such as next-generation sequencing, FISH, PCR or another appropriate assay.
Which medicines are used for ROS1-positive lung cancer?
Internationally used ROS1 inhibitors include crizotinib, entrectinib and repotrectinib. The choice depends on previous treatment, brain involvement, resistance findings, availability and individual clinical factors.
Is ROS1-targeted therapy used for every lung cancer?
No. It is relevant only when a ROS1 alteration is confirmed. Treatment of lung cancer without this molecular target follows different pathways.

Our services are FREE
We connect you with leading hospitals and specialists in India. You pay the hospital directly.


